Find Your Broker
Share Name Share Symbol Market Type Share ISIN Share Description
Tiziana Life Sciences LSE:TILS London Ordinary Share GB00BKWNZY55 ORD 3P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -2.75p -4.31% 61.00p 60.00p 62.00p 64.00p 59.00p 64.00p 33,000 16:35:05
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -8.3 -6.4 - 77.43

Tiziana Share Discussion Threads

Showing 576 to 599 of 600 messages
Chat Pages: 24  23  22  21  20  19  18  17  16  15  14  13  Older
DateSubjectAuthorDiscuss
26/11/2018
11:40
Note that the stock price of a dual-listed company should be approximately the same in both jurisdictions, after taking currency differences and transaction costs into account. Otherwise arbitrageurs would step in and exploit the price differences. That said, price divergences do occur from time to time, especially when trading hours do not overlap and there has been a significant price move in one market. Read more: Dual Listing hxxps://www.investopedia.com/terms/d/duallisting.asp#ixzz5XxZ4Fi7W Follow us: Investopedia on Facebook I’m not converting but it’s all a matter of choice. It will cost you to convert to Nasdaq and don’t forget they are multipuls of 10 so odd shares stay on Aim.
stenick
26/11/2018
08:24
What are folk on here doing regarding possible conversion of aim listed shares into ADS's re today's news. No need to as such but what are the benefits or drawbacks anyone? Cheers
jpuff
22/11/2018
09:26
93p on nasdaq, shares released on aim on 23rd. DYOR.
stenick
31/10/2018
10:54
Registration of shares on Nasdaq now filed. Here we go. But I suppose it will be another long wait for more news.At least they are not tight for money now.
stenick
18/10/2018
10:57
£16 million in shares being sold vs a market cap of 132m. So should not be a massive dilution.
wageslave
18/10/2018
09:13
Yes, I noticed that, and thought I must be mistaken.... but sadly not, the share price is down 17.9% (to about 100p), already.
asmodeus
18/10/2018
08:24
Nice offer for the Americans 75p a share. Wouldn't mind a share of that though looks like we might get down to that soon
osammyboy2
28/9/2018
18:54
An offer like that for TILS would give us about 5 Euro, or £4 per share. I'll take that. Anybody got contacts at Roche?
osammyboy2
28/9/2018
15:50
Up to 655 million euro for a pre-clinical companyHTTps://www.tusktherapeutics.com/HTTps://globenewswire.com/news-release/2018/09/28/1586258/0/en/Tusk-Therapeutics-to-be-acquired-by-Roche.html
jpuff
26/9/2018
08:54
Antibody biotech Tiziana Life Sciences sets terms for $16 million Nasdaq IPORenaissance Capital, September 25, 2018, 09:30:00 AM EDT  Tiziana Life Sciences, which is developing antibody therapies to combat NASH, Crohn's disease, MS, and cancer, announced terms for its Nasdaq IPO on Tuesday. The London, United Kingdom-based company plans to raise $16 million by offering 1.575 million ADSs at $10.25, the as-converted price of its shares on London's AIM (symbol: TILS). At that price, Tiziana Life Sciences would command a fully diluted market value of $212 million.  The pre-revenue company was founded in 1998 and plans to list on the Nasdaq under the symbol TLSA. Laidlaw & Company (UK) is the sole bookrunner on the deal. Deal timing was not announced. The article Antibody biotech Tiziana Life Sciences sets terms for $16 million Nasdaq IPO originally appeared on IPO investment manager Renaissance Capital's web site renaissancecapital.com
wageslave
25/9/2018
16:36
50 billion dollar market per year up for grabs.
stenick
30/8/2018
11:32
Found this on net about Milciclib and breast cancer. So much reasearch with good results. Why do things take so long. hxxps://etd.ohiolink.edu/pg_10?0::NO:10:P10_ETD_SUBID:152002
stenick
24/8/2018
07:08
There’s a vote of confidence!
stenick
23/8/2018
12:42
The word 'spray' has made this thread exciting again: Stenick - 16 Aug 2018 - 10:31 A nasal spray to combat Alzheimer's and others, absolutely brilliant!. This blood brain barrier seems to have been a stumbling block,but with Foralumab and Milciclib able to cross it, well what a game changers these will be and Foralumab being fully human. I'm no scientist but I can see the potential. Stenick - 26 Apr 2018 - 07:25 We did and I think we do have a chance of a return. 25p. To 240p to 80p and lots of ups and down in between is a traders dream surely. Nothing has changed they still have some potentially really good products, loads of money, and news to come, all with less than 150mill shares in issue. The crash and Beauforts going bust has not helped the share price I suspect. I'm still hopeful here as I like what I hear about Milciclib and the thought of using a nasal spray to combat auto immune dieseases is appealing to me let alone big pharma. I've recouped some losses and hope for a bit more here.
andrbea
22/8/2018
06:51
Who knows Asmo but with millions of dollars,hopefully,they can get on with getting to market. And with no money issues and only 200mill shares I can see a market cap of 4 to 8 hundred million £ quite achievable to start.
stenick
22/8/2018
06:35
Then can we expect a rise on a re-start, Sten. ?
asmodeus
21/8/2018
16:56
Still along way to go to match past highs, but the day they announce offering to nasdaq there will be a halt in trading
stenick
21/8/2018
15:23
I did sell some holding to cover initial outlay of course.
stenick
21/8/2018
14:39
No Asmodeus, I bought loads at the beginning , so no averaging down, just enjoying the ride with a company I balieve in and hopefully with loads to come.
stenick
21/8/2018
13:35
Have you bought more, Stenick?
asmodeus
21/8/2018
10:06
Shareholder’s resolutions have granted that about 45million shares can be offered to high worth individuals on Nasdaq If Tils starts at approx $2 that’s $90million dollars raised if all sold. Plenty to finance pipeline to market. So the higher share price we get to on Aim the the higher we start on Nasdaq, simples.
stenick
21/8/2018
09:53
Nasdaq listing is imminent I would imagine as it is now a more realistic price to float at, but hay onwards and upwards.
stenick
21/8/2018
08:30
That 14k+ trade at 8:46 is the largest in a while here.
recordz
20/8/2018
18:46
break even £29.05p
twodegrees
Chat Pages: 24  23  22  21  20  19  18  17  16  15  14  13  Older
Your Recent History
LSE
TILS
Tiziana
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20181219 04:21:12